DreamPharm Products:
Lutein-20||Herbs for headache, fever, and migraine ||
Milk thistle||Saw palmetto||
Triple B Super Vision||Garlic, Ginger, and Grapeseed Extract||
Ginseng and Ginkgo||Hair Million||
DHEA||Coenzyme Q10||
Sleep Aid herbal formula - natural sleep aid||Herbal Breath - herbs for bad breath problems.||
Weight loss herbal formula for menopause and pms||Ginkgo biloba||
Colon cleansing, Laxative||ViaVita, Lecithin for healthy liver
Fatty acids resources:
Pathogen research abs 1 || Pathogen research abs 2 || Pathogen research abs 3 || Pathogen research abs 4 || Pathogen research abs 5 ||
Hormone and endocrine research abs 1 || Hormone and endocrine research abs 2 || Hormone and endocrine research abs 3 || Hormone and endocrine research abs 4 || Hormone and endocrine research abs 5
Am J Kidney Dis. 1999 Apr;33(4):778-81.
Recombinant human growth hormone and Gitelman's syndrome.
Ko CW, Koo JH.
Department of Pediatrics, Kyungpook National University School of Medicine, Taegu, South Korea. cwkh.kyungpook.ac.kr
Gitelman's syndrome is a primary renal tubular disorder with hypokalemic metabolic alkalosis, hypocalciuria, and magnesium deficiency. Short stature is one of clinical manifestations in children. The pathogenesis of short stature in Gitelman's syndrome is not known. To evaluate whether growth hormone (GH) is deficient and whether recombinant human GH (rhGH) improves growth rate, rhGH therapy was tried in a child with Gitelman's syndrome. Both height and body weight were less than the third percentile. Laboratory and radiologic findings suggested GH deficiency. During the first 6 months, rhGH therapy with potassium supplement markedly elevated growth rate from 3.8 cm/yr to 12.0 cm/yr. After cessation of rhGH, height increment markedly decreased to the pretreatment level of 3.6 cm/yr during the second 6 months. Additionally, hypomagnesemia was corrected after rhGH therapy. Accordingly, GH deficiency may contribute to short stature in children with Gitelman's syndrome, and rhGH therapy would be an excellent adjunctive treatment for short children with Gitelman's syndrome whose condition is resistant to conventional therapies in terms of growth.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10196023&dopt=Abstract
Reprod Toxicol. 2002 Nov-Dec;16(6):801-8.
Alteration of pregnancy related hormones and fetal survival in F-344 rats exposed by inhalation to benzo(a)pyrene.
Archibong AE, Inyang F, Ramesh A, Greenwood M, Nayyar T, Kopsombut P, Hood DB, Nyanda AM.
Department of Obstetrics/Gynecology, Reproductive Sciences Laboratory, Meharry Medical College, 1005 D B Todd Boulevard, Nashville, TN 37208, USA. aarchibonmc.edu
The objective of this study was to evaluate the effect of subacute exposure to inhaled benzo(a)pyrene (BaP) on fetal survival and luteal maintenance using timed-pregnant Fisher 344 rats. Prior to assignment of pregnant rats to treatment and control groups, numbers of implantation sites were determined on gestation day (GD) 8 via midventral laparotomy. Subsequently, animals were assigned randomly to three treatment groups and two control groups. Treatment consisted of subacute exposure of rats via inhalation to BaP 25, 75, and 100 micro g/m(3), 4h daily for 10 days (GD-11-20). Control animals were either sham exposed to carbon black (CB) to control for inert BaP carrier or remained unexposed (UNC). Blood samples were collected on days 15 and 17 of gestation via sinus orbital veini-puncture for plasma. Number of pups per litter was determined postpartum and fetal survival rate was expressed as a percentage of the corresponding implantation sites. Radioimmunoassays were used to determine plasma progesterone, estrogen, and prolactin (indirect measurement of decidual luteotropin) concentrations. Fetal survival among BaP-treated rats declined in a dose-dependent manner (25 micro g/m(3), 78.3% per litter; 75 micro g/m(3), 38.0% per litter; 100 micro g/m(3), 33.8% per litter; P<0.05) compared with CB (96.7% per litter) and UNC (98.9% per litter). Plasma progesterone, estrogen, and prolactin concentrations also declined as a result of subacute exposure of rats to BaP compared to controls. These data suggest that inhaled BaP compromised fetal survival and consequently luteotropic activity in the exposed animals.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12401509&dopt=Abstract
Cell Signal. 2003 Jan;15(1):47-55.
Jak2 and proteasome activities control the availability of cell surface growth hormone receptors during ligand exposure.
Moulin S, Bouzinba-Segard H, Kelly PA, Finidori J.
INSERM Unit 344, Molecular Endocrinology, Faculty of Medicine Necker, 156 rue de Vaugirard 75730, Paris Cedex 15, France.
Several mechanisms participate in the down-regulation of growth hormone receptor (GHR) signalling under ligand exposure. In CHO cells expressing GHR, we show that ligand stimulation induces degradation of the total cell GHR content. Experiments with 125I-hGH indicate that ligand-bound internalized receptors are not immediately replaced. Using cell surface biotinylation, we demonstrate for the first time that, concomitantly with the degradation of cell surface receptors, GHRs from the intracellular compartments are also degraded. We thus suggest that under prolonged ligand exposure, some GHRs are targeted to the cell surface, while others are routed to degradation compartments. Inhibitors of Jak2 and of the proteasome partially inhibited degradation of cell surface receptors, while these compounds completely inhibit the degradation of intracellular GHRs, resulting in their accumulation. We therefore propose that Jak2 and proteasome activities control the amount of intracellular GHRs, and thus the availability of receptors at the cell surface, during ligand exposure. 2002 Elsevier Science Inc.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12401519&dopt=Abstract
Neurosci Lett. 2002 Nov 15;333(1):21-4.
Transient postnatal thyroxine treatment leads to variation in transmitter binding site densities in the hippocampus of rats.
Roskoden T, Zilles K, Schleicher A, Schwegler H.
Otto-von-Guericke-University, Institute of Anatomy, Leipziger Strasse 44, D-39120 Magdeburg, Germany. thomas.roskodeedzin.uni-magdeburg.de
Newborn rats were treated daily with thyroid hormone (TH) until postnatal day 12. In the adult animals we measured the densities of glutamatergic (N-methyl-D-aspartate (NMDA), amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA), kainic acid (KA)), cholinergic (muscarinic subtype 1 and 2 (M1, M2)), gamma-aminobutyric acid (GABA)ergic (GABA(A)) and serotonergic (5-hydroxytryptamine (5-HT(1A))) binding sites using quantitative receptor-autoradiography with tritiated ligands. In the TH-treated rats the KA binding site density was increased in the stratum oriens of cornu ammonis (CA)3, the terminal field of the infrapyramidal mossy fibers (IPMF). Densities of M2 and 5-HT(1A) were increased in the CA1 region. In contrast, binding site densities for NMDA in the entire hippocampus and for AMPA in the dentate gyrus were reduced, whereas binding site densities for M2 and GABA(A) remained unchanged. From this study we conclude that concomitant with the increase of the IPMF zone the density of the KA binding sites is specifically enhanced. In addition, we found a general shift from binding sites receiving cortical to those receiving subcortical input in the hippocampus. 2002 Elsevier Science Ireland Ltd.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12401551&dopt=Abstract
Neurosci Lett. 2002 Nov 15;333(1):49-53.
Differential regulation of gene expression of neurotensin and prohormone convertases PC1 and PC2 in the bovine ocular ciliary epithelium: possible implications on neurotensin processing.
Ortego J, Wollmann G, Coca-Prados M.
Yale University School of Medicine, Department of Ophthalmology and Visual Science, 330 Cedar Street, New Haven, CT 06510, USA.
Prohormone convertases PC1 and PC2 are enzymes involved in the intracellular processing of pro-neurotensin/neuromedin N (pro-NT/NN) through the regulated secretory pathway. In this study, we present evidence of the differential gene expression of pro-NT/NN, pro-PC1 and pro-PC2 in two cell lines established from the neuroendocrine ocular ciliary epithelium. Dexamethasone and forskolin were found to synergistically up-regulate NT/NN mRNA expression in both cell types. The pigmented cells released NT, and this release was enhanced by agents that induced its biosynthesis. In contrast, nonpigmented cells exhibited a significantly reduced neurotensin secretion in response to inducers, leading to an accumulation of the peptide. PC1 and PC2 mRNA expression was induced in a cell-specific manner by the same agents that enhanced pro-NT/NN biosynthesis. These results demonstrate cell-specific processing of pro-NT/NN by the ciliary epithelium. 2002 Elsevier Science Ireland Ltd.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12401558&dopt=Abstract
Is your hair shedding prematurely? Are you losing hair gradually or all of a sudden, or just as you are aging?
Hair Million is a herbal formula to reverse your hair loss problems.
Numerous anecdotal cases, and personal testimonies indicate that this herbal formula based on Chinese herbs actually
improves the conditions of hair thinning and hair loss for a significant fraction of people taking it regularly.
The biology of hair growth is complex and a field still under exploration.
We don't know how Hair Million stops hair loss, and promotes
hair restoration, despite all the supporting anecdotal cases.
Neither scientific research nor placebo controlled clinical trials has been conducted due to the cost. Shortage of scientific
and clinical research data is not uncommon in herbal and nutritional arena. Important merits of Hair Million is that it is relatively
inexpensive compared with surgical transplantation or prescription drugs, and secondly, it is made only of traditional herbs that
promote hair growth and are widely known to be safe in regular quantities. If you are interested in clinically tested prescription
DreamPharm Online Healthy Supplements ||
Lutein ||
Progesterone Cream ||
Natural herbal formula for hair loss problems ||